These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23088222)

  • 1. The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment.
    Watt AM; Hiller JE; Braunack-Mayer AJ; Moss JR; Buchan H; Wale J; Riitano DE; Hodgetts K; Street JM; Elshaug AG;
    Implement Sci; 2012 Oct; 7():101. PubMed ID: 23088222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups.
    Hodgetts K; Hiller JE; Street JM; Carter D; Braunack-Mayer AJ; Watt AM; Moss JR; Elshaug AG;
    BMC Health Serv Res; 2014 May; 14():204. PubMed ID: 24885716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citizens' Perspectives on Disinvestment from Publicly Funded Pathology Tests: A Deliberative Forum.
    Street JM; Callaghan P; Braunack-Mayer AJ; Hiller JE
    Value Health; 2015 Dec; 18(8):1050-6. PubMed ID: 26686790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging clinicians in evidence-based disinvestment: role and perceptions of evidence.
    Watt AM; Willis CD; Hodgetts K; Elshaug AG; Hiller JE
    Int J Technol Assess Health Care; 2012 Jul; 28(3):211-9. PubMed ID: 22980696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What counts and how to count it: physicians' constructions of evidence in a disinvestment context.
    Hodgetts K; Elshaug AG; Hiller JE
    Soc Sci Med; 2012 Dec; 75(12):2191-9. PubMed ID: 22963922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.
    Uzochukwu BSC; Okeke C; Shuaib F; Torres-Rueda S; Vassall A; Jit M; Nonvignon J; Uzochukwu AC; Ruiz F
    Health Res Policy Syst; 2024 Jun; 22(1):73. PubMed ID: 38926716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FROM TALK TO ACTION: POLICY STAKEHOLDERS, APPROPRIATENESS, AND SELECTIVE DISINVESTMENT.
    Paprica PA; Culyer AJ; Elshaug AG; Peffer J; Sandoval GA
    Int J Technol Assess Health Care; 2015 Jan; 31(4):236-40. PubMed ID: 26290289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of public deliberation methods for gathering input on issues in healthcare: Results from a randomized trial.
    Carman KL; Mallery C; Maurer M; Wang G; Garfinkel S; Yang M; Gilmore D; Windham A; Ginsburg M; Sofaer S; Gold M; Pathak-Sen E; Davies T; Siegel J; Mangrum R; Fernandez J; Richmond J; Fishkin J; Siu Chao A
    Soc Sci Med; 2015 May; 133():11-20. PubMed ID: 25828260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
    Elshaug AG; Hiller JE; Moss JR
    Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustainability in Health care by Allocating Resources Effectively (SHARE) 11: reporting outcomes of an evidence-driven approach to disinvestment in a local healthcare setting.
    Harris C; Allen K; Ramsey W; King R; Green S
    BMC Health Serv Res; 2018 May; 18(1):386. PubMed ID: 29843702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada.
    Bentley C; Costa S; Burgess MM; Regier D; McTaggart-Cowan H; Peacock SJ
    BMC Health Serv Res; 2018 May; 18(1):339. PubMed ID: 29739463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engaging the consumer in disinvestment in public healthcare: Concerns, perspectives and attitudes of older adults.
    Pu D; Bonnici R; Haines T
    J Eval Clin Pract; 2023 Mar; 29(2):320-328. PubMed ID: 36165636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy.
    Bentley C; Peacock S; Abelson J; Burgess MM; Demers-Payette O; Longstaff H; Tripp L; Lavis JN; Wilson MG
    Health Res Policy Syst; 2019 Feb; 17(1):17. PubMed ID: 30732616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology adoption and the politics of governance in the UK.
    Milewa T
    Soc Sci Med; 2006 Dec; 63(12):3102-12. PubMed ID: 16982120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainability in Health care by Allocating Resources Effectively (SHARE) 2: identifying opportunities for disinvestment in a local healthcare setting.
    Harris C; Allen K; King R; Ramsey W; Kelly C; Thiagarajan M
    BMC Health Serv Res; 2017 May; 17(1):328. PubMed ID: 28476159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CONTRIBUTION OF STAKEHOLDER ENGAGEMENT TO THE IMPACT OF A HEALTH TECHNOLOGY ASSESSMENT: AN IRISH CASE STUDY.
    Ryan M; Moran PS; Harrington P; Murphy L; O'Neill M; Whelan M; Teljeur C
    Int J Technol Assess Health Care; 2017 Jan; 33(4):424-429. PubMed ID: 29032786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.